A Prospective Randomized, Double-Blind Comparison of LY900014 to Humalog with an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents with Type 1 Diabetes PRONTO-Peds
The study medication for this research study is called LY900014. It is a type of mealtime insulin. The main reason for you to take part in this study is not to treat you for your diabetes but to help in answering the following research questions:
•Does LY900014 help to lower blood glucose levels in patients with type 1 diabetes?
•How LY900014 controls blood glucose levels compared to Humalog.
- IRB Number: 1906588741
- Research Study Identifier: TX10572
- Principal Investigator: Linda DiMeglio, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required